Pulmonx Quick Ratio 2019-2023 | LUNG

Historical quick ratio values for Pulmonx (LUNG) over the last 10 years.
Pulmonx Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2023-12-31 $0.13B $0.02B 5.77
2023-09-30 $0.13B $0.02B 6.41
2023-06-30 $0.15B $0.02B 7.62
2023-03-31 $0.17B $0.02B 9.70
2022-12-31 $0.15B $0.02B 8.35
2022-09-30 $0.17B $0.02B 7.73
2022-06-30 $0.17B $0.02B 8.49
2022-03-31 $0.18B $0.02B 10.30
2021-12-31 $0.19B $0.02B 10.92
2021-09-30 $0.21B $0.02B 9.57
2021-06-30 $0.22B $0.02B 13.46
2021-03-31 $0.23B $0.01B 16.22
2020-12-31 $0.24B $0.01B 19.10
2020-09-30 $0.05B $0.02B 3.05
2020-06-30 $0.00B 0.00
2020-03-31 $0.00B 0.00
2019-12-31 $0.00B 0.00
2019-09-30 $0.00B 0.00
2018-12-31 $0.01B $0.01B 0.99
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.342B $0.069B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Inspire Medical Systems (INSP) United States $4.855B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Enovis (ENOV) United States $2.779B 20.60
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Clover Health Investments (CLOV) United States $0.431B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
Biotricity (BTCY) United States $0.011B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00